1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2015 Strategies in the Japanese Microbiology Testing Market

2015 Strategies in the Japanese Microbiology Testing Market

  • May 2015
  • -
  • Venture Planning Group
  • -
  • 976 pages

2015 Strategies in the Japanese Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. 

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. 

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. 


Opportunities and Strategic Recommendations


- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,
Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,
Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Market Segmentation Analysis


- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

° Hospitals
° Blood Banks
° Commercial/Private Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.


Current and Emerging Products


- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 976 pages and 160 tables

Table Of Contents

2015 Strategies in the Japanese Microbiology Testing Market
Table of Contents


Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Japan A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market SegmentationPotential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako


List of Tables


Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan Laboratories Performing Infectious Disease Tests By Market Segment
Japan Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
Japan Commercial/Private Laboratories Performing
Infectious Disease Tests by Annual Test Volume
Japan All Market Segments Infectious Disease Test Volume Forecast
Japan Hospital Laboratories Infectious Disease Test
Volume Forecast
Japan Blood Banks Infectious Disease Test Volume Forecast
Japan Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
Japan All Market Segments Infectious Disease Diagnostics
Market Forecast
Japan Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
Japan Blood Banks Infectious Disease Diagnostics Market Forecast
Japan Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
Japan HIV or HIV I/HIV II Test Volume and Diagnostics Sales By Market Segment Forecast
Japan HIVAg Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Adenovirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Aeromonads Test Volume and Diagnostics Sales Forecast By Market Segment
Japan BEA Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Blastocystis Hominis Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan Campylobacter Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Candida Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chancroid Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Coronavirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan CoxsackieVirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Cryptosporidium Test Volume and Diagnostics SalesForecast by Market Segment
Japan Cyclospora Test Volume and Diagnostics Sales Forecast By Market Segment
Japan CMV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan E. Coli Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Echovirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Encephalitis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Enterovirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan EBV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Giardia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Gonorrhea Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan HantaVirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBsAg Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis Delta Test Volume and Diagnostics SalesForecast by Market Segment
Japan HBcAg Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBeAg Test Volume and Diagnostics Sales Forecast By Market Segment
Japan ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan Herpes Type VI Test Volume and Diagnostics SalesForecast by Market Segment
Japan HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan Influenza Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Lyme Disease Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Lymphogranuloma Test Volume and Diagnostics SalesForecast by Market Segment
Japan Malaria Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan Measles Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Meningitis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Microsporidium Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Mononucleosis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Mumps Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Papilloma Virus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Parvovirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Pneumonia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Polyomaviruses Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Pseudomonas Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Rabies Test Volume and Diagnostics Sales Forecast By Market Segment
Japan RSV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Rhinovirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Rotavirus Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Rubella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Salmonella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Septicemia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Shigella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Staphylococci Test Volume and Diagnostics SalesForecast by Market Segment
Japan Streptococci Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Syphilis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Toxoplasmosis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Trichomonas Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Tuberculosis Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Vibrio Test Volume and Diagnostics Sales Forecast By Market Segment
Japan West Nile Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Yersinia Test Volume and Diagnostics Sales Forecast By Market Segment
Japan AIDS Testing Market Diagnostics Sales By Major Supplier
Japan Campylobacter Testing Market Diagnostics Sales By Major Supplier
Japan Candida Testing Market Diagnostics Sales By Major Supplier
Japan Chlamydia Testing Market Diagnostics Sales By Major Supplier
Japan CMV Testing Market Diagnostics Sales By Major Supplier
Japan Gonorrhea Testing Market Diagnostics Sales By Major Supplier
Japan Hepatitis Testing Market Diagnostics Sales By Major Supplier
Japan Hepatitis C Testing Market Diagnostics Sales By Major Supplier
Japan Herpes Testing Market Diagnostics Sales By Major Supplier
Japan Legionella Testing Market Diagnostics Sales Forecast By Major Supplier
Japan Meningitis Testing Market Diagnostics Sales By Major Supplier
Japan Mononucleosis Testing Market Diagnostics Sales By Major Supplier
Japan Mycoplasma Testing Market Diagnostics Sales By Major Supplier
Japan Pneumonia Testing Market Diagnostics Sales By Major Supplier
Japan RSV Testing Market Diagnostics Sales by Major Supplier
Japan Rotavirus Testing Market Diagnostics Sales By Major Supplier
Japan Rubella Testing Market Diagnostics Sales By Major Supplier
Japan Septicemia Testing Market Diagnostics Sales By Major Supplier
Japan Shigella Testing Market Diagnostics Sales By Major Supplier
Japan Streptococci Testing Market Diagnostics Sales By Major Supplier
Japan Syphilis Testing Market Diagnostics Sales By Major Supplier
Japan Toxoplasmosis Testing Market Diagnostics Sales By Major Supplier
Japan Trichomonas Testing Market Diagnostics Sales By Major Supplier
Japan Tuberculosis Testing Market Diagnostics Sales By Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics in South Africa

  • November 2016
    9 pages
  • Infectious Dise...  

  • South Africa  

    Africa  

View report >

Infectious Disease Statistics in France

  • November 2016
    3 pages
  • Infectious Dise...  

    Shellfish  

    Oyster  

  • France  

View report >

Pathology Statistics in Spain

  • November 2016
    3 pages
  • Pathology  

    Infectious Dise...  

  • Spain  

    Europe  

View report >

Related Market Segments :

Infectious Disease
Diagnostics

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.